T. Rowe Price Investment Management’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.96M | Buy |
+90,628
| New | +$3.96M | ﹤0.01% | 585 |
|
|
2024
Q1 | – | Sell |
-1,295,943
| Closed | -$33M | – | 639 |
|
|
2023
Q4 | $33M | Sell |
1,295,943
-314,553
| -20% | -$8.01M | 0.02% | 443 |
|
|
2023
Q3 | $22.4M | Hold |
1,610,496
| – | – | 0.02% | 467 |
|
|
2023
Q2 | $37M | Sell |
1,610,496
-357,679
| -18% | -$8.22M | 0.03% | 416 |
|
|
2023
Q1 | $58.3M | Buy |
1,968,175
+12,198
| +0.6% | +$361K | 0.04% | 345 |
|
|
2022
Q4 | $48.8M | Sell |
1,955,977
-40,552
| -2% | -$1.01M | 0.04% | 358 |
|
|
2022
Q3 | $43.5M | Buy |
+1,996,529
| New | +$43.5M | 0.03% | 364 |
|